Evidence map›Paper›PMID 23780890›Full record

ReviewClinical cancer research : an official journal of the American Association for Cancer Research2013

Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology.

Charles Ferté, Andrew D Trister, Erich Huang, Brian M Bot, Justin Guinney, Frederic Commo, Solveig Sieberts, Fabrice André, Benjamin Besse, Jean-Charles Soria and 1 more

Abstract readReview
In one paragraph

Review in Clinical cancer research : an official journal of the American Association for Cancer Research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Blocking and randomization to improve molecular biomarker discovery.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Charles FertéSage Bionetworks, Seattle, WA 98109, USA.
Andrew D Trister
Erich Huang
Brian M Bot
Justin Guinney
Frederic Commo
Solveig Sieberts
Fabrice André
Benjamin Besse
Jean-Charles Soria
Stephen H Friend

Funding

Integrating cancer datasets for predictive model development and trainingU54CA149237 · NCI · SAGE BIONETWORKS · PI FRIEND, STEPHEN HENRY · 2010 to 2014
$8.9M
NCI NIH HHS U54 CA149237NCI NIH HHS U54CA149237
6 · The paper itself

Abstract

The progressive introduction of high-throughput molecular techniques in the clinic allows for the extensive and systematic exploration of multiple biologic layers of tumors. Molecular profiles and classifiers generated from these assays represent the foundation of what the National Academy describes as the future of "precision medicine". However, the analysis of such complex data requires the implementation of sophisticated bioinformatic and statistical procedures. It is critical that oncology practitioners be aware of the advantages and limitations of the methods used to generate classifiers to usher them into the clinic. This article uses publicly available expression data from patients with non-small cell lung cancer to first illustrate the challenges of experimental design and preprocessing of data before clinical application and highlights the challenges of high-dimensional statistical analysis. It provides a roadmap for the translation of such classifiers to clinical practice and makes key recommendations for good practice.

Indexed as

Computational BiologyHigh-Throughput Nucleotide SequencingAnimalsCarcinoma, Non-Small-Cell LungGene Expression ProfilingHumansLung NeoplasmsMolecular Targeted TherapyNeoplasmsQuality ControlResearch DesignTranslational Research, Biomedical

Identifiers

PMID23780890
PMCPMC3745509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.